Immediate Impact
50 standout
Citing Papers
Recent advances in molecular mechanisms of skin wound healing and its treatments
2024 Standout
Multiple myeloma
2024 Standout
Works of Mónica Ballesteros being referenced
The MUK five protocol: a phase II randomised, controlled, parallel group, multi-centre trial of carfilzomib, cyclophosphamide and dexamethasone (CCD) vs. cyclophosphamide, bortezomib (Velcade) and dexamethasone (CVD) for first relapse and primary refractory multiple myeloma
2016
An impaired transendothelial migration potential of chronic lymphocytic leukemia (CLL) cells can be linked to ephrin-A4 expression
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mónica Ballesteros | 100 | 93 | 50 | 77 | 24 | 387 | |
| Jennifer J. Wilkes | 113 | 75 | 37 | 27 | 36 | 458 | |
| Ch. Urban | 61 | 136 | 73 | 46 | 38 | 378 | |
| Graham McIlroy | 66 | 50 | 51 | 62 | 25 | 357 | |
| Hana Golan | 56 | 45 | 26 | 41 | 31 | 385 | |
| V. Rodriguez | 162 | 119 | 43 | 20 | 18 | 393 | |
| Tejaswi Kandula | 147 | 41 | 41 | 59 | 20 | 427 | |
| Georgios Trimis | 67 | 46 | 18 | 103 | 24 | 401 | |
| Kyung Nam Koh | 103 | 189 | 76 | 22 | 28 | 386 | |
| Xia Liu | 44 | 43 | 134 | 38 | 30 | 383 | |
| Albert Català | 57 | 74 | 26 | 44 | 35 | 351 |
All Works
Login with ORCID to disown or claim papers
Loading papers...